KURA - Kura Oncology, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $-0.72
|
Rev Est: $34.7M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.50
DETAILS
HIGH:
$40.00
LOW:
$20.00
MEDIAN:
$33.00
CONSENSUS:
$31.50
UPSIDE:
275.89%
Market Cap:
729.21M
Volume:
1,731,633
Avg Volume:
1,515,601
52 Week Range:
5.41-12.49
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.24
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
192
IPO Date:
2015-09-16
EPS (TTM):
-2.02
P/E Ratio:
-4.31
Revenue (TTM):
53.88M
Total Assets:
760.16M
Total Debt:
16.59M
Cash & Equiv:
224.46M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-25.0%
Debt/Equity:
0.04
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $-0.85 | $-0.57 | -49.1% | $20.8M | $51.4M | -59.7% |
| 2025-08-07 | $-0.75 | $0.15 | -600.0% | $15.3M | $64.9M | -76.5% |
| 2025-05-01 | $-0.66 | $-0.51 | -29.4% | $14.1M | $66.7M | -78.8% |
| 2025-02-26 | $-0.22 | $-0.65 | +66.2% | $53.9M | $58.0M | -7.0% |
| 2024-11-07 | $-0.63 | $-0.64 | +1.6% | — | $58.0M | — |
| 2024-08-08 | $-0.59 | $-0.63 | +6.3% | — | — | — |
| 2024-05-02 | $-0.59 | $-0.56 | -5.4% | — | — | — |
| 2024-02-27 | $-0.55 | $-0.56 | +1.8% | $1.3M | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (173.98M) | (152.63M) | (135.84M) | (130.47M) | (89.62M) | (63.14M) | (60.45M) | (35.43M) | (27.56M) | (22.62M) | (11.01M) | (27,315) |
| EPS | -2.02 | -2.08 | -2.03 | -1.97 | -1.69 | -1.51 | -1.72 | -1.52 | -1.47 | -2.28 | -2.69 | -0.01 |
| Total Assets | 760.16M | 448.94M | 456.31M | 534.05M | 647.21M | 241.97M | 182.38M | 95.85M | 69.82M | 87.26M | 1.38M | 9,068 |
| Total Debt | 16.59M | 17.20M | 14.02M | 6.88M | 14.98M | 7.75M | 7.50M | 7.10M | 7.32M | 0 | 2.53M | 220,000 |
| Cash & Equivalents | 224.46M | 37.32M | 51.80M | 90.67M | 325.49M | 26.14M | 16.12M | 11.43M | 9.72M | 15.44M | 1.12M | 6,568 |
| Operating Cash Flow | 134.32M | (124.82M) | (110.06M) | (104.55M) | (69.83M) | (54.76M) | (48.66M) | (28.44M) | (25.35M) | (17.93M) | (2,547) | (24,418) |
| Free Cash Flow | 133.84M | (124.99M) | (110.69M) | (105.70M) | (72.00M) | (54.76M) | (48.66M) | (28.44M) | (25.35M) | (17.99M) | (2,631) | (24,418) |
| FCF per Share | 1.55 | -1.71 | -1.65 | -1.59 | -1.36 | -1.31 | -1.38 | -1.22 | -1.36 | -1.81 | -0.00 | -0.00 |
| Book Value | 413.64M | 397.27M | 420.28M | 506.61M | 610.90M | 218.78M | 160.99M | 79.86M | 56.88M | 82.10M | (3.43M) | (123,957) |
| Cash & ST Investments | 727.39M | 423.96M | 437.99M | 517.96M | 633.32M | 236.89M | 178.99M | 93.14M | 67.79M | 85.75M | 1.12M | 6,568 |
| ROC Equity | -0.42 | -0.38 | -0.32 | -0.26 | -0.15 | -0.29 | -0.38 | -0.44 | -0.48 | -0.28 | N/A | N/A |